10-Q Filing

GUIDED THERAPEUTICS INC CIK: 924515 Q3 2014

Filing Information

Form Type	10-Q
Accession Number	`0001121781-14-000322`
Period End Date	20140930
Filing Date	20141112
Fiscal Year	2014
Fiscal Period	Q3
XBRL Instance	gthp-20140930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 76 Cash Flow Statement 68

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$400.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$18.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$45.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$42.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$124.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $45 and $18 at	`AccountsReceivableNet`	$417.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $45 and $18 at	`AccountsReceivableNet`	$133.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$184.00K	USD	Point-in-time
Inventory, net of reserves of $124 and $184, at September 30, 2014 and	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$1.20M	USD	Point-in-time
Inventory, net of reserves of $124 and $184, at September 30, 2014 and	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$1.19M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$101.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$431.00K	USD	Point-in-time
Series B convertible preferred stock par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Series B convertible preferred stock par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Series B convertible preferred stock shares authorized	`PreferredStockSharesAuthorized`	3,000.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.04M	USD	Point-in-time
Series B convertible preferred stock shares authorized	`PreferredStockSharesAuthorized`	3,000.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.09M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$706.00K	USD	Point-in-time
Series B convertible preferred stock, Issued	`PreferredStockSharesIssued`	1,277.00	shares	Point-in-time
Series B convertible preferred stock, Issued	`PreferredStockSharesIssued`	1,737.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$920.00K	USD	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$132.00K	USD	Point-in-time
Series B convertible preferred stock, Outstanding	`PreferredStockSharesOutstanding`	1,277.00	shares	Point-in-time
Series B convertible preferred stock, Outstanding	`PreferredStockSharesOutstanding`	1,737.00	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$356.00K	USD	Point-in-time
Debt issuance cost, net	`DeferredFinanceCostsNet`	$790.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Debt issuance cost, net	`DeferredFinanceCostsNet`	-	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.28M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.63M	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
TOTAL ASSETS	`Assets`	$3.72M	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	70.48M	shares	Point-in-time
TOTAL ASSETS	`Assets`	$3.32M	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	79.38M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	70.48M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	79.38M	shares	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$35.00K	USD	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$564.00K	USD	Point-in-time
Current portion of long-term note payable	`ShortTermBorrowings`	$109.00K	USD	Point-in-time
Current portion of long-term note payable	`ShortTermBorrowings`	$118.00K	USD	Point-in-time
Short-term notes payable, net of discount	`ShorttermNotesPayableNetOfDiscount`	$851.00K	USD	Point-in-time
Short-term notes payable, net of discount	`ShorttermNotesPayableNetOfDiscount`	-	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.66M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$891.00K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$723.00K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$914.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$14.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$10.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.77M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.12M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$1.55M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$1.25M	USD	Point-in-time
Long-term debt payable, less current portion	`LongTermDebtNoncurrent`	$40.00K	USD	Point-in-time
Long-term debt payable, less current portion	`LongTermDebtNoncurrent`	$103.00K	USD	Point-in-time
Convertible Debt, net of discount	`ConvertibleLongTermNotesPayable`	$2.26M	USD	Point-in-time
Convertible Debt, net of discount	`ConvertibleLongTermNotesPayable`	-	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$1.65M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$3.55M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$3.42M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$7.67M	USD	Point-in-time
Series B convertible preferred stock, $.001 par value; 3,000 shares authorized, 1,532 and 1,737 shares issued and outstanding as of June 30, 2014 and December 31, 2013, respectively (liquidation preference of $1.5 million and $2.1 million as of June 30, 2014 and December 31, 2013, respectively).	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$1.14M	USD	Point-in-time
Series B convertible preferred stock, $.001 par value; 3,000 shares authorized, 1,532 and 1,737 shares issued and outstanding as of June 30, 2014 and December 31, 2013, respectively (liquidation preference of $1.5 million and $2.1 million as of June 30, 2014 and December 31, 2013, respectively).	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$678.00K	USD	Point-in-time
Common stock, $.001 Par value; 145,000,000 shares authorized, 75,495,469 and 70,478,961 shares issued and outstanding as of June 30, 2014 and December 31, 2013, respectively.	`CommonStockValue`	$71.00K	USD	Point-in-time
Common stock, $.001 Par value; 145,000,000 shares authorized, 75,495,469 and 70,478,961 shares issued and outstanding as of June 30, 2014 and December 31, 2013, respectively.	`CommonStockValue`	$79.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$105.27M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$101.84M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-109.84M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-103.03M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-107.00K	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.94M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.32M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.72M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Contract and grant revenue	`Revenues`	$22.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$86.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$52.00K	USD	3 Qtrs
Contract and grant revenue	`Revenues`	$474.00K	USD	3 Qtrs
Sales - devices and disposables	`SalesDevicesAndDisposables`	$306.00K	USD	3 Qtrs
Sales - devices and disposables	`SalesDevicesAndDisposables`	$58.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$586.00K	USD	3 Qtrs
Sales - devices and disposables	`SalesDevicesAndDisposables`	$262.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$260.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$394.00K	USD	3 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$117.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$723.00K	USD	3 Qtrs
Gross Loss (Loss)	`GrossProfit`	$-59.00K	USD	1 Quarter
Gross Loss (Loss)	`GrossProfit`	$2.00K	USD	1 Quarter
Gross Loss (Loss)	`GrossProfit`	$-88.00K	USD	3 Qtrs
Gross Loss (Loss)	`GrossProfit`	$-137.00K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$892.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.24M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$596.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.12M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$249.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$135.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$608.00K	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$762.00K	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$822.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.55M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.41M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.79M	USD	3 Qtrs
Total	`OperatingExpenses`	$1.67M	USD	1 Quarter
Total	`OperatingExpenses`	$6.43M	USD	3 Qtrs
Total	`OperatingExpenses`	$2.44M	USD	1 Quarter
Total	`OperatingExpenses`	$5.64M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-5.26M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-2.42M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.64M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-6.52M	USD	3 Qtrs
OTHER INCOME / (LOSS)	`OtherIncome`	$14.00K	USD	3 Qtrs
OTHER INCOME / (LOSS)	`OtherIncome`	$289.00K	USD	3 Qtrs
OTHER INCOME / (LOSS)	`OtherIncome`	$9.00K	USD	1 Quarter
OTHER INCOME / (LOSS)	`OtherIncome`	$213.00K	USD	1 Quarter
CHANGES IN FAIR VALUE OF WARRANTS	`DerivativeGainLossOnDerivativeNet`	-	USD	3 Qtrs
CHANGES IN FAIR VALUE OF WARRANTS	`DerivativeGainLossOnDerivativeNet`	$266.00K	USD	3 Qtrs
CHANGES IN FAIR VALUE OF WARRANTS	`DerivativeGainLossOnDerivativeNet`	$-195.00K	USD	1 Quarter
CHANGES IN FAIR VALUE OF WARRANTS	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
INTEREST EXPENSE	`InterestExpense`	$35.00K	USD	3 Qtrs
INTEREST EXPENSE	`InterestExpense`	$445.00K	USD	3 Qtrs
INTEREST EXPENSE	`InterestExpense`	$371.00K	USD	1 Quarter
INTEREST EXPENSE	`InterestExpense`	$11.00K	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$5.00M	USD	3 Qtrs
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$6.68M	USD	3 Qtrs
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$1.44M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$2.97M	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	3 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	3 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-1.44M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-5.00M	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$-6.68M	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$-2.97M	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	-	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-128.00K	USD	3 Qtrs
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-1.17M	USD	3 Qtrs
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-39.00K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-6.81M	USD	3 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.01M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-6.17M	USD	3 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.44M	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.09	USD	3 Qtrs
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.09	USD	3 Qtrs
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	65,212.00	shares	3 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	74,052.00	shares	3 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	66,261.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	77,651.00	shares	1 Quarter

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.44M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.00M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-6.68M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.97M	USD	1 Quarter
Bad debt expense	`BadDebtRecovery`	$7.00K	USD	3 Qtrs
Bad debt expense	`BadDebtRecovery`	$32.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$344.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$359.00K	USD	3 Qtrs
Stock based compensation	`ShareBasedCompensation`	$699.00K	USD	3 Qtrs
Stock based compensation	`ShareBasedCompensation`	$852.00K	USD	3 Qtrs
Warrants	`Warrants1`	$-210.00K	USD	3 Qtrs
Warrants	`Warrants1`	$-301.00K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$296.00K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$11.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-11.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-316.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-330.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$12.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$57.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$774.00K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-3.00K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-4.00K	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$639.00K	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$9.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$184.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-64.00K	USD	3 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$544.00K	USD	3 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$1.88M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-4.46M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-4.81M	USD	3 Qtrs
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$111.00K	USD	3 Qtrs
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$144.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-144.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-111.00K	USD	3 Qtrs
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	3 Qtrs
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$2.21M	USD	3 Qtrs
Proceed from issuance of common stock	`ProceedFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceed from issuance of common stock	`ProceedFromIssuanceOfCommonStock`	$201.00K	USD	3 Qtrs
Proceeds from debt financing	`ProceedsFromIssuanceOfDebt`	$4.57M	USD	3 Qtrs
Proceeds from debt financing	`ProceedsFromIssuanceOfDebt`	-	USD	3 Qtrs
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$1.92M	USD	3 Qtrs
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$67.00K	USD	3 Qtrs
Payments on notes and loan payables	`PaymentsOfLoanCosts`	$459.00K	USD	3 Qtrs
Payments on notes and loan payables	`PaymentsOfLoanCosts`	$320.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.38M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.92M	USD	3 Qtrs
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-644.00K	USD	3 Qtrs
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-571.00K	USD	3 Qtrs
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$400.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$42.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$400.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$42.00K	USD	Point-in-time
Cash paid for Interest	`InterestPaid`	$11.00K	USD	3 Qtrs
Cash paid for Interest	`InterestPaid`	$33.00K	USD	3 Qtrs
Deemed dividends on preferred stock	`DeemedDividendsOnPreferredStock`	-	USD	3 Qtrs
Deemed dividends on preferred stock	`DeemedDividendsOnPreferredStock`	$1.17M	USD	3 Qtrs
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	$463.00K	USD	3 Qtrs
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	$355.00K	USD	3 Qtrs
Debt issuance cost paid via warrants	`DebtIssuanceCostPaidViaWarrants`	$522.00K	USD	3 Qtrs
Debt issuance cost paid via warrants	`DebtIssuanceCostPaidViaWarrants`	-	USD	3 Qtrs
Conversion of convertible debt into common stock	`ConversionOfConvertibleDebtIntoCommonStock`	-	USD	3 Qtrs
Conversion of convertible debt into common stock	`ConversionOfConvertibleDebtIntoCommonStock`	$800.00K	USD	3 Qtrs
Conversion of accrued expenses into common stock / options	`DeemedDividendsInFormOfConvertibleWarrantsIntoCommonStock`	-	USD	3 Qtrs
Conversion of accrued expenses into common stock / options	`DeemedDividendsInFormOfConvertibleWarrantsIntoCommonStock`	$178.00K	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.